Skip to content
ARS Pharma
  • About
  • In Development
  • Stay Connected
  • Investors & Media
    • Home
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financial Filings
      • SEC Filings
    • IR Resources
      • Email Alerts
      • Contact Us
  • Careers
  • Contact Us

AAAAI Poster Presentation

ARS-1 (neffy® Nasal Spray) 2.0 mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis

AAAAI 2023: Poster 14

AAAAI 2023: Full Poster 14 Manuscript

Product is for Investigational Use; neffy is the proposed trade name, not yet FDA approved, and might change.

About
In Development
Stay Connected
Investors & Media
Careers
Contact Us
Twitter Linkedin-in

Copyright 2023 © ARS Pharmaceuticals. All rights reserved.  Privacy Policy

Login